Patient preferences for same-day bilateral eye injections of dexamethasone
Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections
This study is trying to see how patients feel about getting eye injections in both eyes on the same day instead of having to come back for separate visits.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rigshospitalet, Denmark Academic / other |
| Locations | 1 site (Glostrup Municipality) |
| Trial ID | NCT06894017 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patient preferences regarding same-day bilateral intravitreal dexamethasone injections, which are used to treat conditions like diabetic macular edema and retinal vein occlusion. The study aims to understand the practical aspects and patient experiences associated with receiving these injections in both eyes during a single visit. By gathering data through questionnaires, the research will assess how patients feel about this treatment approach compared to traditional methods that require separate visits. The findings could help inform future treatment protocols and improve patient satisfaction.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 who have received at least one intravitreal dexamethasone implant and can communicate in Danish.
Not a fit: Patients who have not received an intravitreal dexamethasone implant in the last 12 months will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more efficient treatment options for patients requiring bilateral eye injections, reducing the burden of multiple visits.
How similar studies have performed: Previous studies have shown that same-session bilateral procedures are safe and preferred by patients, indicating a positive outlook for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria * Having received at least one intravitreal dexamethasone implant in either eye * \>18 years of age * Capacity to comprehend and answer questions in Danish language * Signed informed consent Exclusion criteria • No intravitreal dexamethasone implant received within the last 12 months
Where this trial is running
Glostrup Municipality
- Department of Ophthalmology, Rigshospitalet — Glostrup Municipality, Denmark (Recruiting)
Study contacts
- Principal investigator: Miklos Schneider, MD, PhD — Rigshospitalet, Denmark
- Study coordinator: Lena Michelle Mørup Andersen, MScN
- Email: lena.michelle.moerup.andersen@regionh.dk
- Phone: +4538634700
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.